investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Mechanisms of Chromosomal Translocation
Peter Aplan
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Masahiro Onozawa
Hokkaido University of Education
Sapporo, Japan
Peter Aplan
National Cancer Institute (NIH)
Rockville, United States
Related projects
Ying Zhang
Physiological and pathological functions of E3 ubiquitin ligases Smurfs
All cancers but non-melanoma skin cancer
Joel Schneider
Design and Utility of Novel Proteinaceous Biomaterials
All cancers but non-melanoma skin cancer
Pathology
R Andrew Byrd
Methods Development
All cancers but non-melanoma skin cancer
Jon Clardy
Novel Therapeutic Agents from the Bacterial Symbionts of Brazilian Invertebrates
All cancers but non-melanoma skin cancer
Jill P Mesirov
Knowledge-based Gene Expression Analysis for Biomedical and Cancer Research
All cancers but non-melanoma skin cancer
Stuart Le Grice
HIV-1 RNase H as a Therapeutic Target
All cancers but non-melanoma skin cancer
Thomas A Gerken
Initiation and regulation of mucin-type O-glycosylation
All cancers but non-melanoma skin cancer
Alexander Gimelbrant
(PQD4) Epigenetic loss of heterozygosity as a driver of the cancer field effect
All cancers but non-melanoma skin cancer
Patrick J. Sinko
Multifunctional PEG Hydrogel Nano/Microparticles for Targeted Treatment of NSCLC
All cancers but non-melanoma skin cancer